CT (computer tomography) Doctors in Israel — Page 2

Dr. Jacob Cohen is a gynecologist who uses CT (computer tomography) for surgical planning at Assuta Medical Center.

• Specializes in endoscopic operations – performing surgeries through tiny incisions rather than large openings
• Leads laparoscopic procedures – uses camera-guided tools for minimally invasive internal imaging and treatment
• Practices at Assuta Medical Center – Israel's largest private healthcare facility and diagnostic hub

Dr. Hodaya Cohen is a specialist at Hadassah Medical Center. She uses CT imaging to help manage complex cases in women's health.

• Board-certified in obstetrics and gynecology
• Expert in identifying conditions affecting the female reproductive system
• Practices at a premier medical institution in Israel
• Focuses on accurate diagnosis for effective treatment planning

Professor Yoram Kluger is a leading specialist in oncological surgery at Rambam Medical Center. He uses CT scans to plan complex cancer operations.

• Specializes in surgical oncology at a major Israeli medical facility
• Holds the title of Professor of Surgery
• Focuses on the diagnosis and surgical treatment of tumors

Dr. Karen Drumea is a radiotherapy and oncology specialist at Rambam Medical Center. She uses imaging like CT scans to plan precise cancer treatments.

• Specializes in oncology and radiotherapy at a major Israeli medical facility
• Integrates imaging results into personal cancer care plans
• Focuses on technical accuracy for radiation targeting and tumor monitoring

Prof. Beni Boursi leads gastrointestinal cancer research at Sheba Medical Center. He uses CT scans to develop predictive models for early cancer detection.

• Trained in medical oncology at MD Anderson and the Mayo Clinic
• Completed a fellowship in gastrointestinal oncology at the University of Pennsylvania
• Published research in the journal Science on cancer development and treatment
• Founded the ECOG-ACRIN Microbiome Working Group to improve cancer therapy
• Develops models for early diagnosis of pancreatic and colorectal cancers

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Anton Wohl is the Director of the Brain Tumors Unit at Sheba Medical Center. He specializes in neuro-oncology and complex brain tumor surgery. He completed fellowships at the Mayo Clinic in the USA. Dr. Wohl works at a hospital ranked 7th globally by Newsweek in 2026. He focuses on removing tumors while preserving neurological function.

• Performs awake craniotomy and fluorescence-guided surgery to protect brain function.
• Uses intraoperative MRI and functional brain mapping during complex procedures.
• Author of multiple peer-reviewed studies on glioblastoma and innovative therapies.
• Holds Israeli board certification and an active medical license.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Prof. Gil Raviv is a specialist in andrology and reconstructive urology at Sheba Medical Center. Forbes named him among the Best Doctors in Israel. He is the director of the Andrology Unit. Dr. Raviv focuses on male infertility, sexual health, and urethral reconstruction. He works at Sheba, a Top 10 world-ranked hospital.

• Performs specialized sperm retrieval techniques including micro-TESE, TESA, and MESA.
• Treats complex conditions like erectile dysfunction, Peyronie’s disease, and azoospermia.
• Uses microsurgical methods and robotic systems for prostate and urological procedures.
• Provides stem cell therapy and shockwave treatment for sexual dysfunction.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.